Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02567110 · ClinicalTrials.gov registry record
Magnetic Resonance Spectroscopy (MRS) in Midlife Depression
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 169
- Enrollment target
NCT02567110: Completed study, sponsored by Emory University.
NCT02567110 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 169 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02567110 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 169 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact of inflammation on central nervous system (CNS) glutamate, white matter pathology and alterations in behavior and cognition in middle-aged patients with major depression. Depression is associated with significant alterations in glutamate concentrations and white matter integrity, which has been associated with decreased antidepressant response, poor functional outcome, and cognitive impairment.
Primary Outcome
Single-voxel MRS (Magnetic Resonance Spectroscopy) scans will be done to determine the glutamate levels in the basal ganglia. MRS uses a magnetic field to look at magnetic nuclei which absorb and re-emit electromagnetic energy in the presence of the magnetic field. By looking at the peaks in the resultant spectra, the structure and concentrations of metabolite can be determined.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2016-07 |
| Est. Completion | 2022-02-04 |
What the finished NCT02567110 record still lists
NCT02567110 is an observational study that tracks outcomes without assigning an intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02567110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02567110 about?
NCT02567110 is a clinical study titled "Magnetic Resonance Spectroscopy (MRS) in Midlife Depression". The purpose of this study is to determine the impact of inflammation on central nervous system (CNS) glutamate, white matter pathology and alterations in behavior and cognition in middle-aged patients with major depression. Depression is associated with significant alterations in glutamate concentra...
What is the current status of trial NCT02567110?
This trial is currently completed. The enrollment target is 169 participants. The study started on 2016-07. Estimated completion is 2022-02-04.
Who is sponsoring clinical trial NCT02567110?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia